世界の更年期障害治療市場2027

【英語タイトル】Global Menopause Treatment Market Research Report—Forecast till 2027

Market Research Futureが出版した調査資料(MRF20OT079)・商品コード:MRF20OT079
・発行会社(調査会社):Market Research Future
・発行日:2020年10月12日
・ページ数:137
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Online Access)USD4,450 ⇒換算¥462,800見積依頼/購入/質問フォーム
Enterprisewide Price(印刷可)USD6,250 ⇒換算¥650,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、更年期障害治療の世界市場について調査・分析し、エグゼクティブサマリー、イントロダクション、調査手法、市場動向、市場要因分析、治療別市場規模(ホルモン療法、非ホルモン療法)、流通経路別市場規模(病院薬局、小売薬局、オンラインストア)、地域別市場規模、競争状況、企業概要などの項目を掲載しています。
・エグゼクティブサマリー
・イントロダクション
・調査手法
・市場動向
・市場要因分析
・更年期障害治療の世界市場規模:治療別(ホルモン療法、非ホルモン療法)
・更年期障害治療の世界市場規模:流通経路別(病院薬局、小売薬局、オンラインストア)
・更年期障害治療の世界市場規模:地域別
・競争状況
・企業概要
【レポートの概要】

Global Menopause Treatment Market Research Report—Forecast till 2027

[Market Synopsis]
Global Menopause Treatment Market is estimated to exhibit a CAGR of 6.18% during the review period of 2020 to 2027, to surpass USD 15,456.3 Million by 2027. Menopause is an end of women’s menstrual cycle and it is often termed as FMP (Final Menstrual Period). The increasing older female population and the increasing government initiatives to promote women’s health are expected to boost the market of the global menopause treatment market during the review period.
Global Menopause Treatment Market is evaluated to exhibit healthy growth during the assessment period owing to the increasing older female population and growing product launches. Nonetheless, side-effects such as blood clots, heart attacks, strokes, and breast cancer from hormonal treatments are estimated to hinder the market growth during the study period. According to MRFR research, the US, approximately 1.3 million women become menopausal each year, this will also propel the regional market by 2027.

[Market Segmentation]
Global Menopause Treatment Market has been classified into Treatment and Distribution Channels. In terms of the treatment segment, the global market has been categorized into hormonal treatment and non-hormonal treatment. The hormonal treatment type is further bifurcated into estrogen, progesterone, and combination. The non-hormonal treatment is further divided into antiV-depressants and others
Based on the distribution channel, the global menopause treatment market has been classified into hospital pharmacies, retail pharmacies, and online stores. The hospital pharmacies segment was the dominating segment of the market in 2019.

[Regional Analysis]
Geographically, the Global Menopause Treatment Market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas have been segmented into North America and Latin America, with the North American market further divided into the US and Canada.

The Americas are anticipated to dominate the market menopause treatment owing to the rising number of product launches and the growing number of geriatric women in the region. As per the MRFR study, approximately six thousand women reach menopause every day in the US. Europe is accounted for the second-largest market share in the menopause treatment market followed by the Asia Pacific. The regional market is spread across western Europe and Eastern Europe. The increasing adoption of vasomotor symptoms and urogenital complications in women, new product launches, and the existence of developed healthcare infrastructure in most European countries are expected to fuel the market growth during the review period.

Asia-Pacific is anticipated to witness the fastest market growth in the global menopause treatment market over the forecast period owing to rising awareness related to women’s health, coupled with major players entering into tie-ups with regional vendors and distributors.

In the Middle East, the adoption rate of menopause therapies was high in countries such as South Africa, the UAE, and Saudi Arabia.

[Major Players]
The Key Players in the Global Menopause Treatment Market are Novo Nordisk A/S (Denmark), Pfizer Inc. (US), Allergan (Ireland), Eli Lily and Company (US), Emcure Pharmaceuticals Ltd (India), Novartis AG (Switzerland), Cipla Inc. (India), Teva Pharmaceuticals (Israel), Merck & Co., Inc. (US), Abbott Laboratories (US), and others.

[COVID 19 Impacts]
We are continuously tracking the impact of COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

【レポートの目次】

TABLE OF CONTENT
1 EXECUTIVE SUMMARY
1.1 OVERVIEW 14

1.1.1 MARKET SYNOPSIS 14

2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 15

2.2 RESEARCH OBJECTIVE 15

2.3 LIST OF ASSUMPTIONS 16

3 RESEARCH METHODOLOGY
3.1.1 OVERVIEW 18

3.2 DATA MINING 18

3.3 SECONDARY RESEARCH 19

3.4 PRIMARY RESEARCH 20

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 20

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 21

3.5 FORECASTING TECHNIQUES 21

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22

3.6.1 BOTTOM-UP APPROACH 23

3.6.2 TOP-DOWN APPROACH 24

3.7 DATA TRIANGULATION 25

3.8 VALIDATION 25

4 MARKET DYNAMICS
4.1 OVERVIEW 26

4.2 DRIVERS 27

4.2.1 INCREASING OLDER FEMALE POPULATION 27

4.2.2 INCREASING PRODUCT LAUNCHES 27

4.2.3 DRIVERS IMPACT ANALYSIS 28

4.3 RESTRAINTS 28

4.3.1 SIDE-EFFECTS FROM HORMONAL TREATMENTS 28

4.3.2 RESTRAINTS IMPACT ANALYSIS 28

4.4 CHALLENGES 29

4.4.1 LACK OF AWARENESS 29

5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 30

5.1.1 THREAT OF NEW ENTRANTS 31

5.1.2 BARGAINING POWER OF SUPPLIERS 31

5.1.3 THREAT OF SUBSTITUTES 31

5.1.4 BARGAINING POWER OF BUYERS 31

5.1.5 INTENSITY OF RIVALRY 31

5.2 VALUE CHAIN ANALYSIS 32

5.2.1 R&D AND DESIGNING 33

5.2.2 MANUFACTURING 33

5.2.3 DISTRIBUTION 33

5.2.4 MARKETING & SALES 33

6 GLOBAL MENOPAUSE TREATMENT MARKET, BY TREATMENT
6.1 OVERVIEW 34

6.2 HORMONAL TREATMENT 36

6.3 NON-HORMONAL TREATMENT 37

7 GLOBAL MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL
7.1 OVERVIEW 38

7.2 HOSPITAL PHARMACIES 40

7.3 RETAIL PHARMACIES 40

7.4 ONLINE STORES 41

8 GLOBAL MENOPAUSE TREATMENT MARKET, BY REGION
8.1 OVERVIEW 42

8.2 AMERICAS 44

8.2.1 NORTH AMERICA 47

8.2.2 LATIN AMERICA 53

8.3 EUROPE 56

8.3.1 WESTERN EUROPE 59

8.3.2 EASTERN EUROPE 73

8.4 ASIA-PACIFIC 76

8.4.1 JAPAN 79

8.4.2 CHINA 81

8.4.3 INDIA 83

8.4.4 AUSTRALIA 85

8.4.5 SOUTH KOREA 87

8.4.6 REST OF ASIA-PACIFIC 89

8.5 MIDDLE EAST & AFRICA 92

8.5.1 SAUDI ARABIA 94

8.5.2 UNITED ARAB EMIRATES 96

8.5.3 OMAN 98

8.5.4 KUWAIT 100

8.5.5 QATAR 102

8.5.6 REST OF MIDDLE EAST & AFRICA 104

9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW 107

9.2 COMPETITIVE BENCHMARKING 108

9.3 GLOBAL MENOPAUSE TREATMENT MARKET: COMPANY SHARE ANALYSIS 109

9.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 109

9.5 MAJOR GROWTH STRATEGY IN THE GLOBAL MENOPAUSE TREATMENT MARKET 110

9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 110

9.6.1 NEW PRODUCT LAUNCHES 110

9.6.2 ACQUISITIONS 110

9.7 FINANCIAL MATRIX 111

10 COMPANY PROFILES
10.1 PFIZER INC. 112

10.1.1 COMPANY OVERVIEW 112

10.1.2 FINANCIAL OVERVIEW 113

10.1.3 PRODUCTS/SERVICES OFFERED 113

10.1.4 KEY DEVELOPMENTS 114

10.1.5 SWOT ANALYSIS 114

10.1.6 KEY STRATEGIES 114

10.2 NOVO NORDISK A/S 115

10.2.1 COMPANY OVERVIEW 115

10.2.2 FINANCIAL OVERVIEW 115

10.2.3 PRODUCTS/SERVICES OFFERED 116

10.2.4 KEY DEVELOPMENTS 116

10.2.5 SWOT ANALYSIS 116

10.2.6 KEY STRATEGIES 117

10.3 NOVARTIS AG 118

10.3.1 COMPANY OVERVIEW 118

10.3.2 FINANCIAL OVERVIEW 118

10.3.3 PRODUCTS/SERVICES OFFERED 119

10.3.4 KEY DEVELOPMENTS 119

10.3.5 SWOT ANALYSIS 119

10.3.6 KEY STRATEGIES 120

10.4 MERCK & CO., INC. 121

10.4.1 COMPANY OVERVIEW 121

10.4.2 FINANCIAL OVERVIEW 121

10.4.3 PRODUCTS/SERVICES OFFERED 122

10.4.4 KEY DEVELOPMENTS 122

10.4.5 SWOT ANALYSIS 122

10.4.6 KEY STRATEGIES 122

10.5 ELI LILY AND COMPANY 123

10.5.1 COMPANY OVERVIEW 123

10.5.2 FINANCIAL OVERVIEW 123

10.5.3 PRODUCTS/SERVICES OFFERED 124

10.5.4 KEY DEVELOPMENTS 124

10.5.5 SWOT ANALYSIS 124

10.5.6 KEY STRATEGIES 124

10.6 ALLERGAN 125

10.6.1 COMPANY OVERVIEW 125

10.6.2 FINANCIAL OVERVIEW 125

10.6.3 PRODUCTS/SERVICES OFFERED 126

10.6.4 KEY DEVELOPMENTS 126

10.6.5 SWOT ANALYSIS 126

10.6.6 KEY STRATEGIES 126

10.7 EMCURE PHARMACEUTICALS LTD 127

10.7.1 COMPANY OVERVIEW 127

10.7.2 FINANCIAL OVERVIEW 127

10.7.3 PRODUCTS/SERVICES OFFERED 127

10.7.4 KEY DEVELOPMENTS 127

10.7.5 SWOT ANALYSIS 128

10.7.6 KEY STRATEGIES 128

10.8 CIPLA INC. 129

10.8.1 COMPANY OVERVIEW 129

10.8.2 FINANCIAL OVERVIEW 129

10.8.3 PRODUCTS/SERVICES OFFERED 129

10.8.4 KEY DEVELOPMENTS 129

10.8.5 SWOT ANALYSIS 130

10.8.6 KEY STRATEGIES 130

10.9 TEVA PHARMACEUTICALS 131

10.9.1 COMPANY OVERVIEW 131

10.9.2 FINANCIAL OVERVIEW 131

10.9.3 PRODUCTS/SERVICES OFFERED 132

10.9.4 KEY DEVELOPMENTS 132

10.9.5 SWOT ANALYSIS 132

10.9.6 KEY STRATEGIES 133

10.10 ABBOTT LABORATORIES 134

10.10.1 COMPANY OVERVIEW 134

10.10.2 FINANCIAL OVERVIEW 134

10.10.3 PRODUCTS/SERVICES OFFERED 135

10.10.4 KEY DEVELOPMENTS 135

10.10.5 SWOT ANALYSIS 135

10.10.6 KEY STRATEGIES 135

11 APPENDIX
11.1 REFERENCES 136

11.2 RELATED REPORTS 136

12 LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS 16

TABLE 2 GLOBAL MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 35

TABLE 3 GLOBAL MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY REGION, 2017–2027 (USD MILLION) 36

TABLE 4 GLOBAL MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 36

TABLE 5 GLOBAL MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY REGION, 2017–2027 (USD MILLION) 37

TABLE 6 GLOBAL MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 37

TABLE 7 GLOBAL MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 39

TABLE 8 GLOBAL MENOPAUSE TREATMENT MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2017–2027 (USD MILLION) 40

TABLE 9 GLOBAL MENOPAUSE TREATMENT MARKET, FOR RETAIL PHARMACIES, BY REGION, 2017–2027 (USD MILLION) 40

TABLE 10 GLOBAL MENOPAUSE TREATMENT MARKET, FOR ONLINE STORES, BY REGION, 2017–2027 (USD MILLION) 41

TABLE 11 GLOBAL MENOPAUSE TREATMENT MARKET, BY REGION, 2017–2027 (USD MILLION) 43

TABLE 12 AMERICAS: MENOPAUSE TREATMENT MARKET, BY REGION, 2017–2027 (USD MILLION) 45

TABLE 13 AMERICAS: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 45

TABLE 14 AMERICAS: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 45

TABLE 15 AMERICAS: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 46

TABLE 16 AMERICAS: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 46

TABLE 17 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 47

TABLE 18 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 47

TABLE 19 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 48

TABLE 20 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 48

TABLE 21 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 49

TABLE 22 US: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 49

TABLE 23 US: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 50

TABLE 24 US: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 50

TABLE 25 US: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 51

TABLE 26 CANADA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 51

TABLE 27 CANADA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 52

TABLE 28 CANADA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 52

TABLE 29 CANADA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 53

TABLE 30 LATIN AMERICA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 53

TABLE 31 LATIN AMERICA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 54

TABLE 32 LATIN AMERICA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 54

TABLE 33 LATIN AMERICA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 55

TABLE 34 EUROPE: MENOPAUSE TREATMENT MARKET, BY REGION, 2017–2027 (USD MILLION) 57

TABLE 35 EUROPE: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 57

TABLE 36 EUROPE: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 57

TABLE 37 EUROPE: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 58

TABLE 38 EUROPE: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 58

TABLE 39 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 59

TABLE 40 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 60

TABLE 41 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 60

TABLE 42 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 61

TABLE 43 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 61

TABLE 44 GERMANY: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 61

TABLE 45 GERMANY: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 62

TABLE 46 GERMANY: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 62

TABLE 47 GERMANY: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 63

TABLE 48 FRANCE: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 63

TABLE 49 FRANCE: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 64

TABLE 50 FRANCE: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 64

TABLE 51 FRANCE: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 65

TABLE 52 UK: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 65

TABLE 53 UK: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 66

TABLE 54 UK: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 66

TABLE 55 UK: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 67

TABLE 56 ITALY: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 67

TABLE 57 ITALY: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 68

TABLE 58 ITALY: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 68

TABLE 59 ITALY: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 69

TABLE 60 SPAIN: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 69

TABLE 61 SPAIN: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 70

TABLE 62 SPAIN: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 70

TABLE 63 SPAIN: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 71

TABLE 64 REST OF WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 71

TABLE 65 REST OF WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 72

TABLE 66 REST OF WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 72

TABLE 67 REST OF WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 73

TABLE 68 EASTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 73

TABLE 69 EASTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 74

TABLE 70 EASTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 74

TABLE 71 EASTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 75

TABLE 72 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 77

TABLE 73 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 77

TABLE 74 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 78

TABLE 75 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 78

TABLE 76 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 79

TABLE 77 JAPAN: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 79

TABLE 78 JAPAN: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 80

TABLE 79 JAPAN: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 80

TABLE 80 JAPAN: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 81

TABLE 81 CHINA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 81

TABLE 82 CHINA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 82

TABLE 83 CHINA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 82

TABLE 84 CHINA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 83

TABLE 85 INDIA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 83

TABLE 86 INDIA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 84

TABLE 87 INDIA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 84

TABLE 88 INDIA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 85

TABLE 89 AUSTRALIA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 85

TABLE 90 AUSTRALIA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 86

TABLE 91 AUSTRALIA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 86

TABLE 92 AUSTRALIA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 87

TABLE 93 SOUTH KOREA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 87

TABLE 94 SOUTH KOREA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 88

TABLE 95 SOUTH KOREA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 88

TABLE 96 SOUTH KOREA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 89

TABLE 97 REST OF ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 89

TABLE 98 REST OF ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 90

TABLE 99 REST OF ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 90

TABLE 100 REST OF ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 91

TABLE 101 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 92

TABLE 102 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 93

TABLE 103 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 93

TABLE 104 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 94

TABLE 105 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 94

TABLE 106 SAUDI ARABIA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 94

TABLE 107 SAUDI ARABIA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 95

TABLE 108 SAUDI ARABIA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 95

TABLE 109 SAUDI ARABIA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 96

TABLE 110 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 96

TABLE 111 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 97

TABLE 112 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 97

TABLE 113 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 98

TABLE 114 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 98

TABLE 115 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 99

TABLE 116 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 99

TABLE 117 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 100

TABLE 118 KUWAIT: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 100

TABLE 119 KUWAIT: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 101

TABLE 120 KUWAIT: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 101

TABLE 121 KUWAIT: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 102

TABLE 122 QATAR: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 102

TABLE 123 QATAR: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 103

TABLE 124 QATAR: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 103

TABLE 125 QATAR: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 104

TABLE 126 REST OF MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 104

TABLE 127 REST OF MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 105

TABLE 128 REST OF MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 105

TABLE 129 REST OF MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 106

TABLE 130 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE MENOPAUSE TREATMENT MARKET 109

TABLE 131 NEW PRODUCT LAUNCHES 110

TABLE 132 ACQUISITIONS 110

TABLE 133 PFIZER INC.: PRODUCTS/SERVICES OFFERED 113

TABLE 134 NOVO NORDISK A/S: PRODUCTS/SERVICES OFFERED 116

TABLE 135 NOVARTIS AG: PRODUCTS/SERVICES OFFERED 119

TABLE 136 MERCK & CO., INC.: PRODUCTS/SERVICES OFFERED 122

TABLE 137 ELI LILY AND COMPANY: PRODUCTS/SERVICES OFFERED 124

TABLE 138 ALLERGAN: PRODUCTS/SERVICES OFFERED 126

TABLE 139 EMCURE PHARMACEUTICALS LTD: PRODUCTS/SERVICES OFFERED 127

TABLE 140 CIPLA INC.: PRODUCTS/SERVICES OFFERED 129

TABLE 141 CIPLA INC.: KEY DEVELOPMENTS 129

TABLE 142 TEVA PHARMACEUTICALS: PRODUCTS/SERVICES OFFERED 132

TABLE 143 TEVA PHARMACEUTICALS: KEY DEVELOPMENTS 132

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS 16

TABLE 2 GLOBAL MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 35

TABLE 3 GLOBAL MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY REGION, 2017–2027 (USD MILLION) 36

TABLE 4 GLOBAL MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 36

TABLE 5 GLOBAL MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY REGION, 2017–2027 (USD MILLION) 37

TABLE 6 GLOBAL MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 37

TABLE 7 GLOBAL MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 39

TABLE 8 GLOBAL MENOPAUSE TREATMENT MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2017–2027 (USD MILLION) 40

TABLE 9 GLOBAL MENOPAUSE TREATMENT MARKET, FOR RETAIL PHARMACIES, BY REGION, 2017–2027 (USD MILLION) 40

TABLE 10 GLOBAL MENOPAUSE TREATMENT MARKET, FOR ONLINE STORES, BY REGION, 2017–2027 (USD MILLION) 41

TABLE 11 GLOBAL MENOPAUSE TREATMENT MARKET, BY REGION, 2017–2027 (USD MILLION) 43

TABLE 12 AMERICAS: MENOPAUSE TREATMENT MARKET, BY REGION, 2017–2027 (USD MILLION) 45

TABLE 13 AMERICAS: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 45

TABLE 14 AMERICAS: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 45

TABLE 15 AMERICAS: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 46

TABLE 16 AMERICAS: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 46

TABLE 17 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 47

TABLE 18 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 47

TABLE 19 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 48

TABLE 20 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 48

TABLE 21 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 49

TABLE 22 US: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 49

TABLE 23 US: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 50

TABLE 24 US: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 50

TABLE 25 US: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 51

TABLE 26 CANADA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 51

TABLE 27 CANADA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 52

TABLE 28 CANADA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 52

TABLE 29 CANADA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 53

TABLE 30 LATIN AMERICA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 53

TABLE 31 LATIN AMERICA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 54

TABLE 32 LATIN AMERICA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 54

TABLE 33 LATIN AMERICA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 55

TABLE 34 EUROPE: MENOPAUSE TREATMENT MARKET, BY REGION, 2017–2027 (USD MILLION) 57

TABLE 35 EUROPE: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 57

TABLE 36 EUROPE: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 57

TABLE 37 EUROPE: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 58

TABLE 38 EUROPE: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 58

TABLE 39 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 59

TABLE 40 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 60

TABLE 41 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 60

TABLE 42 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 61

TABLE 43 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 61

TABLE 44 GERMANY: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 61

TABLE 45 GERMANY: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 62

TABLE 46 GERMANY: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 62

TABLE 47 GERMANY: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 63

TABLE 48 FRANCE: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 63

TABLE 49 FRANCE: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 64

TABLE 50 FRANCE: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 64

TABLE 51 FRANCE: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 65

TABLE 52 UK: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 65

TABLE 53 UK: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 66

TABLE 54 UK: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 66

TABLE 55 UK: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 67

TABLE 56 ITALY: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 67

TABLE 57 ITALY: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 68

TABLE 58 ITALY: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 68

TABLE 59 ITALY: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 69

TABLE 60 SPAIN: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 69

TABLE 61 SPAIN: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 70

TABLE 62 SPAIN: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 70

TABLE 63 SPAIN: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 71

TABLE 64 REST OF WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 71

TABLE 65 REST OF WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 72

TABLE 66 REST OF WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 72

TABLE 67 REST OF WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 73

TABLE 68 EASTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 73

TABLE 69 EASTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 74

TABLE 70 EASTERN EUROPE: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 74

TABLE 71 EASTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 75

TABLE 72 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 77

TABLE 73 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 77

TABLE 74 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 78

TABLE 75 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 78

TABLE 76 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 79

TABLE 77 JAPAN: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 79

TABLE 78 JAPAN: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 80

TABLE 79 JAPAN: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 80

TABLE 80 JAPAN: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 81

TABLE 81 CHINA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 81

TABLE 82 CHINA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 82

TABLE 83 CHINA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 82

TABLE 84 CHINA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 83

TABLE 85 INDIA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 83

TABLE 86 INDIA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 84

TABLE 87 INDIA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 84

TABLE 88 INDIA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 85

TABLE 89 AUSTRALIA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 85

TABLE 90 AUSTRALIA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 86

TABLE 91 AUSTRALIA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 86

TABLE 92 AUSTRALIA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 87

TABLE 93 SOUTH KOREA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 87

TABLE 94 SOUTH KOREA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 88

TABLE 95 SOUTH KOREA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 88

TABLE 96 SOUTH KOREA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 89

TABLE 97 REST OF ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 89

TABLE 98 REST OF ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 90

TABLE 99 REST OF ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 90

TABLE 100 REST OF ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 91

TABLE 101 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 92

TABLE 102 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 93

TABLE 103 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 93

TABLE 104 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 94

TABLE 105 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 94

TABLE 106 SAUDI ARABIA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 94

TABLE 107 SAUDI ARABIA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 95

TABLE 108 SAUDI ARABIA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 95

TABLE 109 SAUDI ARABIA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 96

TABLE 110 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 96

TABLE 111 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 97

TABLE 112 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 97

TABLE 113 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 98

TABLE 114 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 98

TABLE 115 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 99

TABLE 116 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 99

TABLE 117 UNITED ARAB EMIRATES: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 100

TABLE 118 KUWAIT: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 100

TABLE 119 KUWAIT: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 101

TABLE 120 KUWAIT: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 101

TABLE 121 KUWAIT: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 102

TABLE 122 QATAR: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 102

TABLE 123 QATAR: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 103

TABLE 124 QATAR: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027 (USD MILLION) 103

TABLE 125 QATAR: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 104

TABLE 126 REST OF MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2017–2027 (USD MILLION) 104

TABLE 127 REST OF MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, FOR HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 105

TABLE 128 REST OF MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, FOR NON-HORMONAL TREATMENT, BY TYPE, 2017–2027

(USD MILLION) 105

TABLE 129 REST OF MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 106

TABLE 130 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE MENOPAUSE TREATMENT MARKET 109

TABLE 131 NEW PRODUCT LAUNCHES 110

TABLE 132 ACQUISITIONS 110

TABLE 133 PFIZER INC.: PRODUCTS/SERVICES OFFERED 113

TABLE 134 NOVO NORDISK A/S: PRODUCTS/SERVICES OFFERED 116

TABLE 135 NOVARTIS AG: PRODUCTS/SERVICES OFFERED 119

TABLE 136 MERCK & CO., INC.: PRODUCTS/SERVICES OFFERED 122

TABLE 137 ELI LILY AND COMPANY: PRODUCTS/SERVICES OFFERED 124

TABLE 138 ALLERGAN: PRODUCTS/SERVICES OFFERED 126

TABLE 139 EMCURE PHARMACEUTICALS LTD: PRODUCTS/SERVICES OFFERED 127

TABLE 140 CIPLA INC.: PRODUCTS/SERVICES OFFERED 129

TABLE 141 CIPLA INC.: KEY DEVELOPMENTS 129

TABLE 142 TEVA PHARMACEUTICALS: PRODUCTS/SERVICES OFFERED 132

TABLE 143 TEVA PHARMACEUTICALS: KEY DEVELOPMENTS 132



LIST OF FIGURES
FIGURE 1 GLOBAL MENOPAUSE TREATMENT MARKET STRUCTURE 17

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 23

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL MENOPAUSE TREATMENT MARKET 26

FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MENOPAUSE TREATMENT MARKET 30

FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL MENOPAUSE TREATMENT MARKET 32

FIGURE 6 GLOBAL MENOPAUSE TREATMENT MARKET SHARE, BY TREATMENT, 2019 (%) 34

FIGURE 7 GLOBAL MENOPAUSE TREATMENT MARKET, BY TREATMENT, 2019 AND 2027 (USD MILLION) 35

FIGURE 8 GLOBAL MENOPAUSE TREATMENT MARKET SHARE, BY DISTRIBUTION CHANNEL, 2019 (%) 38

FIGURE 9 GLOBAL MENOPAUSE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019 AND 2027 (USD MILLION) 39

FIGURE 10 GLOBAL MENOPAUSE TREATMENT MARKET SHARE, BY REGION, 2019 (%) 42

FIGURE 11 GLOBAL MENOPAUSE TREATMENT MARKET, BY REGION, 2019 AND 2027 (USD MILLION) 43

FIGURE 12 AMERICAS: MENOPAUSE TREATMENT MARKET, BY REGION, 2019 AND 2027 (USD MILLION) 44

FIGURE 13 NORTH AMERICA: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2019 AND 2027 (USD MILLION) 47

FIGURE 14 EUROPE: MENOPAUSE TREATMENT MARKET, BY REGION, 2019 AND 2027 (USD MILLION) 56

FIGURE 15 WESTERN EUROPE: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2019 AND 2027 (USD MILLION) 59

FIGURE 16 ASIA-PACIFIC: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2019 AND 2027 (USD MILLION) 76

FIGURE 17 MIDDLE EAST & AFRICA: MENOPAUSE TREATMENT MARKET, BY COUNTRY, 2019 AND 2027 (USD MILLION) 92

FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS 108

FIGURE 19 MAJOR MANUFACTURERS COMPANY SHARE ANALYSIS, 2019 (%) 109

FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL MENOPAUSE TREATMENT MARKET 110

FIGURE 21 SALES & OPERATING INCOME MARGIN, 2019 111

FIGURE 22 R&D EXPENDITURE, 2019 111

FIGURE 23 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT 113

FIGURE 24 PFIZER INC.: SWOT ANALYSIS 114

FIGURE 25 NOVO NORDISK A/S: FINANCIAL OVERVIEW SNAPSHOT 115

FIGURE 26 NOVO NORDISK A/S: SWOT ANALYSIS 116

FIGURE 27 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT 118

FIGURE 28 NOVARTIS AG: SWOT ANALYSIS 119

FIGURE 29 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT 121

FIGURE 30 MERCK & CO., INC.: SWOT ANALYSIS 122

FIGURE 31 ELI LILY AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT 123

FIGURE 32 ELI LILY AND COMPANY: SWOT ANALYSIS 124

FIGURE 33 ALLERGAN: FINANCIAL OVERVIEW SNAPSHOT 125

FIGURE 34 ALLERGAN: SWOT ANALYSIS 126

FIGURE 35 EMCURE PHARMACEUTICALS LTD: SWOT ANALYSIS 128

FIGURE 36 CIPLA INC.: SWOT ANALYSIS 130

FIGURE 37 TEVA PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT 131

FIGURE 38 TEVA PHARMACEUTICALS: SWOT ANALYSIS 132

FIGURE 39 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT 134

【掲載企業】

Novo Nordisk A/S (Denmark), Pfizer Inc. (US), Allergan (Ireland), Eli Lily and Company (US), Emcure Pharmaceuticals Ltd (India), Novartis AG (Switzerland), Cipla Inc. (India), Teva Pharmaceuticals (Israel), Merck & Co., Inc. (US), Abbott Laboratories (US), and others

★調査レポート[世界の更年期障害治療市場2027] (コード:MRF20OT079)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の更年期障害治療市場2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆